Watchpatone
Payments companies reported to CMS as associated with Watchpatone. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Watchpatone, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Watchpatone
These are the largest totals companies reported as associated with Watchpatone. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Chandra Matadeen-Ali | Glen Mills, PA | Sleep Medicine (Internal Medicine) | $938,189.02 |
| Alan Schwartz | Baltimore, MD | Pulmonary Disease | $238,755.57 |
| Matthew Schmitt | Atlanta, GA | Critical Care Medicine (Internal Medicine) | $26,939.70 |
| Atul Malhotra | San Diego, CA | Sleep Medicine (Internal Medicine) | $24,094.63 |
| Dale Yoo | Mckinney, TX | Clinical Cardiac Electrophysiology | $15,986.67 |
| David Rawitscher | Plano, TX | Cardiovascular Disease | $11,156.02 |
| Alan Brown | Naperville, IL | Cardiovascular Disease | $6,061.42 |
| Yelena Tumashova | Des Plaines, IL | $5,996.87 | |
| Daniel Bensimhon | Greensboro, NC | Advanced Heart Failure and Transplant Cardiology | $5,456.75 |
| Omar Burschtin | New York, NY | Sleep Medicine (Internal Medicine) | $3,822.14 |
Prescribed Watchpatone?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.